Edition:
United Kingdom

People: Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

730.00GBp
18 Jun 2019
Change (% chg)

-7.00 (-0.95%)
Prev Close
737.00
Open
770.00
Day's High
770.00
Day's Low
723.00
Volume
33,098
Avg. Vol
73,436
52-wk High
1,064.38
52-wk Low
575.32

Henderson, Stuart 

Mr. Stuart Henderson has been appointed as Non-Executive Director of the Company, effective 1 June 2016. He joins Oxford BioMedica from Deloitte, where he was Head of European Healthcare and Life Sciences and also served on the Global Industry Team for seven years between 2004 and 2011. Prior to this he was Partner at Arthur Andersen from 1982 to 2002, where he sat on the Andersen Global Life Sciences Team as Head of Emerging Biotechnology. Mr. Henderson has extensive experience in audit and transaction support practice and has worked with life science businesses from start up to multinational as well as acting as reporting accountant on numerous IPO and Class 1 transactions. He has reported as Audit Partner to the audit committees of publicly quoted companies for over 20 years. Mr Henderson is a former director of the Babraham Institute and currently sits as an observer on the board of OneNucleus, the Life Sciences trade body for Cambridge and London.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --